Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistBased on limited metadata, Leaf of Life LLC received an FDA Warning Letter on August 4, 2022, from the Office of Human and Animal Food- West Division II regarding unapproved new drugs and misbranding violations. The company appears to have marketed drug products without required FDA approval and/or with misleading labeling or claims. This enforcement action falls under FDA's regulatory authority over drug products and their marketing compliance.